European Medicines Agency (EMA) Patients' and Consumers'(PCWP) and Healthcare Professionals' (HCPWP) Working Parties joint meeting

• Date:
  Otrdiena, 2 Marts 2021, Visu dienu
• Vieta:
  Online
  European Medicines Agency, Amsterdam, the Netherlands

This year’s first ‘Patient and Consumer’ (PCWP) and ‘Healthcare Professionals’ (HCPWP) Working Parties joint meeting will be introduced by EMA’s new Executive Director.

During the first day, there will be an update on COVID-19 vaccines and therapeutics, on the European Reference Network model in the European Data Space, Advanced Therapy Medicinal Products (ATMPs) and finally on personalised medicine approaches for the next generation of medicines.

On the second day, the PCWP/HCPWP discussion will focus on Big Data and on ICH Guidances on Good Clinical Practice (E6/E8). The final part of the meeting will be dedicated to an overview of the 2020 Satisfaction Survey results on interactions with EMA.

Documents

Agenda - PCWP/HCPWP joint meeting on 2-3 March 2021

Draft Reference Number: EMA/62114/2021

Meeting Summary - PCWP HCPWP joint meeting March 2021

Reference Number: EMA/158664/2021

Presentation - Update on COVID-19 vaccines and therapeutics (M.Cavaleri, EMA)

Presentation - Pharmacovigilance and public safety updates for COVID-19 vaccines (G.Genov, P.Bahri, EMA)

Presentation - COVID-19 vaccines outreach strategy (M.Carr, EMA)

Presentation - EMA's third public stakeholder meeting (N.Bere, EMA)

Presentation - The European Reference Network model in the European Data Space: Potential collaboration between European research networks and EMA (J.Llinares Garcia, EMA)

Presentation - The European Reference Network model in the European Data Space: European Joint Programme on Rare Diseases (R.Nabbout, APHP)

Presentation - Timely patient access to Advanced Therapy Medicinal Products (ATMPs) (M.Schüssler-Lenz, CAT)

Presentation - Personalised medicine approaches for the next generation of medicines (E.Moltzen, IC PerMed)

Presentation - Implementation of HMA-EMA Big Data Steering Group deliverables (P.Arlett, EMA; N.Brun, DKMA)

Presentation - Good Clinical Practice (F.Sweeney, EMA)

Presentation - EMA/FDA Patient-Focused Drug Development ICH Reflection Paper (M.Bonelli, EMA)

Presentation - Satisfaction survey: What fo the 2020 results tell us? (M.Mavris, EMA)